Table 2.
Groups | No. of mice | Dosage and route (i.p.) | Survival days |
ILS (%) | T/C (%) | |
---|---|---|---|---|---|---|
Mean ± SD | Range | |||||
Control | 5 | Normal saline | 41.6 ± 7.3 | 34–49 | ||
Lycorine | 5 | 5 mg/kg/day | 54.2 ± 13.8*,# | 38–71 | 30.0 | 130 |
Lycorine | 5 | 10 mg/kg/day | 55.8 ± 10.2**,## | 39–64 | 34.0 | 134 |
Ara-C | 5 | 20 mg/kg/day | 42.8 ± 9.8 | 30–52 | 3.0 | 103 |
Female BALB/c SCID mice (3–5 weeks old) were injected i.v. with 5 × 106 HL-60 cells. Treatment of lycorine or Ara-C was started 1 day after the HL-60 cell injection. T/C, treated vs. control; ILS, increased life span. *P = 0.024, compared with control group; #P = 0.011, compared with the Ara-C treated group; **P = 0.007, compared with control group; ##P = 0.002, compared with the Ara-C treated group.